Multiple myeloma: open trials in Greece

40 open trials have a site in Greece. Registry data; only the trial team decides who can take part.

NCT06285318
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
Research · Janssen-Cilag Ltd.
University Hospital of Alexandroupolis, Alexandroupoli · Laiko General Hospital of Athens, Athens · Alexandra Hospital, Athens · University Hospital of Crete, PAGNI, Heraklion · Ioannina University Hospital, Ioannina · University Hospital of Larissa, Larissa · G Papanikolaou Hospital of Thessaloniki, Thessaloniki · AHEPA University General Hospital of Thessaloniki, Thessaloniki · Anticancer Hospital of Thessaloniki Theageneio, Thessaloniki
Registry updated 2026-08-28
NCT07227311
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 2 · GlaxoSmithKline
University General Hospital of Alexandroupoli, Alexandroupoli · General Hospital of Athens - Alexandra, Athens · Evangelismos S A, Athens · University General Hospital of Ioannina, Ioannina · Theageneio Cancer Hospital, Thessaloniki · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki
Registry updated 2026-08-25
2023-503404-89-00
A study to evaluate the Safety, Pharmacokinetics, and Activity of Subcutaneous Cevostamab (BFCR4350A) in Patients with Relapsed or Refractory Multiple Myeloma (CAMMA 3)
Trial Treatment · Phase 1 · Genentech Inc.
Evangelismos S A, Athens · Alexandra Hospital, Athens
Registry updated 2026-08-24
NCT05020236
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Trial Treatment · Phase 3 · Pfizer
Evaggelismos Hospital, Athens · Alexandra Hospital, Athens · University General Hospital of Ioannina, Ioannina · Theageneio Cancer Hospital, Thessaloniki
Registry updated 2026-08-24
NCT06152575
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Trial Treatment · Phase 3 · Pfizer
University Hospital of Alexandroupolis, Alexandroupolis · Evangelismos S A, Athens · Alexandra Hospital, Athens · University General Hospital of Ioannina, Ioannina · Theageneio Cancer Hospital, Thessaloniki · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki
Registry updated 2026-08-24
NCT05714839
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Trial Treatment · Phase 1/2 · GlaxoSmithKline
General Hospital of Athens - Alexandra, Athens · Athens Medical Center S.A., Thessaloniki
Registry updated 2026-08-19
NCT06292780
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Alexandra Hospital, Athens
Registry updated 2026-08-18
2023-505775-70-00
A multi-center, open-label, phase 2 study of Elranatamab in patients with high-risk smoldering multiple myeloma
Trial Treatment · Phase 2 · European Myeloma Network B.V.
Alexandra Hospital, Athens
Registry updated 2026-08-03
2025-525105-20-00
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax (ABBV-453) Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Trial Treatment · Phase 1/2 · AbbVie Deutschland GmbH & Co. KG
General Hospital of Athens - Alexandra, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Registry updated 2026-07-15
NCT07642362
Digital Support for Multiple Myeloma Quality of Life
Trial Treatment · CareAcross
Alexandra General Hospital, Athens
Registry updated 2026-06-11
NCT06679101
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Trial Treatment · Phase 3 · GlaxoSmithKline
University General Hospital of Alexandroupoli, Alexandroupoli · Alexandra Hospital, Athens · Evaggelismos Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General University Hospital Of Patras, Patras · Theageneio Cancer Hospital, Thessaloniki
Registry updated 2026-04-22
NCT06932562
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Trial Treatment · Phase 3 · European Myeloma Network B.V.
University General Hospital of Alexandroupoli, Alexandroupoli · Evangelismos S A, Athens · Alexandra Hospital, Athens · Theageneio Cancer Hospital, Thessaloniki
Registry updated 2026-03-25
NCT05879757
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
Research · Takeda
Alexandra General Hospital, Athens · General Hospital of Thessaloniki "G. Papanikolaou", Thessaloniki
Registry updated 2026-02-18
NCT06237803
European Myeloma Network (EMN) Sample Project
Research · European Myeloma Network B.V.
Regional General Hospital Alexandra Dept of Clinical Therapeutics, Athens · Theagenion Cancer Hospital, Thessaloniki
Registry updated 2025-12-03
NCT06636552
An Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of Alternating Bortezomib-Based Regimens in Combination With DaratUMumab Followed by Maintenance With Daratumumab in the Frontline Setting of Primary Plasma CEll L
Trial Treatment · Phase 2 · Hellenic Society of Hematology
Hematology Department, University General Hospital of Alexandroupolis, Alexandroupoli · Hematology Clinic, General Hospital of Athens "Evanggelismos", Athens · 1st Propaedeutic Department, "Laiko" General Hospital of Athens, Athens · Hematology Department "Alexandra" General Hospital of Athens, Athens · Hematology Department, Regional General Hospital for Cancer Treatment "Metaxa" of Piraeus, Piraeus · Hematology Department, Theageneion Cancer Hospital, Thessaloniki · Hematology Department, General Hospital of Thessaloniki "Papanikolaou", Thessaloniki
Registry updated 2024-10-10

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error